Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Pharma
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
One of three key launches for Takeda's next phase of growth, Mimrylo is the first drug for polycythemia vera that mimics hepcidin.
Angus Liu
Aug 28, 2026 10:04pm
Of biopharma's top 25 companies, 9 had double-digit sales bumps
Aug 12, 2026 11:47am
Takeda, Daiichi, Astellas and more—Fierce Pharma Asia
Aug 7, 2026 8:35am
FDA approves Takeda's first-in-class Orzeyful for narcolepsy
Aug 6, 2026 11:10am
Legend Biotech, Merck, Otsuka—Fierce Pharma Asia
Jul 31, 2026 9:00am
Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia
Jul 24, 2026 9:00am
